+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sacral Nerve Stimulation"

From
Neurostimulation: Technologies and Global Markets - Product Thumbnail Image

Neurostimulation: Technologies and Global Markets

  • Report
  • September 2023
  • 160 Pages
  • Global
From
Neuromodulation - Global Strategic Business Report - Product Thumbnail Image

Neuromodulation - Global Strategic Business Report

  • Report
  • May 2024
  • 298 Pages
  • Global
From
Neuroprosthetics - Global Strategic Business Report - Product Thumbnail Image

Neuroprosthetics - Global Strategic Business Report

  • Report
  • May 2024
  • 193 Pages
  • Global
From
From
Neuromodulation Global Market Report 2024 - Product Thumbnail Image

Neuromodulation Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Neuroprosthetics Global Market Report 2024 - Product Thumbnail Image

Neuroprosthetics Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Neurostimulation Devices Global Market Report 2024 - Product Thumbnail Image

Neurostimulation Devices Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
From
Loading Indicator

Sacral nerve stimulation (SNS) is a type of neuromodulation therapy used to treat a variety of neurological conditions. It involves the implantation of a small device that sends electrical signals to the sacral nerve, which is located near the tailbone. The device is used to reduce symptoms such as urinary and fecal incontinence, chronic pelvic pain, and overactive bladder. It is also used to treat certain types of constipation. SNS is a minimally invasive procedure that is typically performed in an outpatient setting. It is considered a safe and effective treatment option for many patients. The device is programmed to deliver electrical signals to the sacral nerve, which can help reduce symptoms and improve quality of life. The SNS market is a growing segment of the neurology devices industry. It is expected to continue to grow as more patients seek out this treatment option. Companies in the SNS market include Medtronic, Boston Scientific, St. Jude Medical, and Nevro. Show Less Read more